Xcout Intel
Healx
Healx is an AI-native pharmaceutical company that uses artificial intelligence and technology to discover and develop new treatments for rare diseases. The company redevelops, combines, and enhances known compounds to build a drug pipeline aimed at delivering effective therapies to patients.
Subscribe to see Healx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Healx at a glance
Healx is a biotech company headquartered in Cambridge, United Kingdom, founded in 2014. It has raised at least $49M across the 2 funding rounds on record. Its most recent funding round, Series C, raised $47M in August 2024. Xcout recorded 2 job postings from Healx in the last 90 days.
Healx funding rounds
At least $49M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $47M | 10 named | |
| Seed | $2M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Healx
Xcout recorded 2 job postings from Healx in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Healx's hiring signals →
Investors
Tech stack
Healx competitors
A few of Healx's closest competitors — see the full list of competitors and alternatives →
1910 Genetics is a biotechnology company that integrates artificial intelligence with biology to accelerate drug discovery. Their mission is to reduce the timeline and cost of developing treatments for genetic diseases.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
MetaBIX Biotech is a biotechnology company leveraging artificial intelligence to advance its research and development. The firm has raised early capital through its investment rounds.
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Herophilus is a neurotherapeutics discovery company headquartered in San Francisco, California. The company utilizes artificial intelligence, human stem cell models, and phenotypic screening platforms to discover and develop new drugs for neurodegenerative and neurological diseases.
Get Healx's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Healx? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Healx in Xcout Intel
- 2 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access